L. Capolongo

发表

Novel phenyl nitrogen mustard and half-mustard derivatives of distamycin A

Laura Capolongo, Nicola Mongelli, Enzio Ragg, 1997 .

Phenyl sulfur mustard derivatives of distamycin A.

P. Cozzi, C. Geroni, E. Ragg, 2000, Bioorganic & medicinal chemistry letters.

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.

D. Ballinari, E. Pesenti, G. Pezzoni, 1991, British Journal of Cancer.

Representing cell cycle data.

P. Ubezio, L. Capolongo, 1986, Cytometry.

A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

H. Dombret, H. Kantarjian, J. Cortes, 2015, Haematologica.

Flow cytometric detection of glutathione S-transferase isoenzymes by quantitative immunofluorescence under nonsaturating conditions.

A. Pifferi, G. Tagliabue, P. Ubezio, 1995, Cytometry.

Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives

M. Caruso, M. Ripamonti, L. Capolongo, 2004, Investigational New Drugs.

Novel anthracycline analogs.

D. Ballinari, G. Pezzoni, L. Capolongo, 1990, Cancer treatment reviews.

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).

M. Broggini, L. Capolongo, N. Mongelli, 1993, British Journal of Cancer.

PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.

C. Sawyers, G. Martinelli, R. Paquette, 2007 .

Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent.

P. Ubezio, M. D’Incalci, G. Taraboletti, 1987, European journal of cancer & clinical oncology.

The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule

P. Ubezio, F. Sola, D. Moneta, 1999, Cancer Chemotherapy and Pharmacology.

Danusertib Hydrochloride (PHA-739358), a Multi-Kinase Aurora Inhibitor, Elicits Clinical Benefit in Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia .

H. Dombret, N. Boissel, P. Schafhausen, 2009 .

Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR

W. T. Beck, M. Mariani, L. Capolongo, 2004, Investigational New Drugs.

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells.

F. Cavalli, M. Ghielmini, V. Torri, 1997, British Journal of Cancer.

Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.

G. Spalluto, B. Cacciari, A. Zaid, 1997, Farmaco.

The alkylating antitumor drug tallimustine does not induce DNA repair.

R. Rossi, A. Montecucco, O. Chevallier-Lagente, 1996, Anticancer research.

Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.

S. Marchini, M. Ciomei, F. Fiorentini, 2001, Cancer research.

Novel phenyl nitrogen mustard and half-mustard derivatives of amidino-modified distamycin

Laura Capolongo, Nicola Mongelli, Paolo Cozzi, 1997 .

Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.

F. Zunino, G. Capranico, M. Binaschi, 1994, Molecular pharmacology.

Pharmacological and Toxicological Aspects of 4-Demethoxy-3 *-deamino-3 *-aziridinyl-4 *-methylsulphonyl-daunorubicin ( PNU-159548 ) : A Novel Antineoplastic Agent 1

S. Marchini, M. Ciomei, F. Fiorentini, 2001 .

Synthesis and Antitumor Activity of 6–Substituted Purine and Deazapurine Nucleosides

G. Cristalli, E. Pesenti, S. Vittori, 1991 .

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).

M. Ciomei, W. Pastori, C. Geroni, 1995, British Journal of Cancer.

DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and-resistant human colon carcinoma cells

M. D’Incalci, L. Capolongo, G. Belvedere, 2004, Cancer Chemotherapy and Pharmacology.

Synthesis and cytotoxic activity of alkylidene- and alkyl-substituted camptothecins

M. Ciomei, W. Cabri, A. Bedeschi, 1997 .

Synthesis and antitumor activity of a new class of water soluble camptothecin derivatives

M. Ciomei, W. Cabri, A. Bedeschi, 1996 .

Synthesis and Antitumor Activity of a New Class of Water Soluble Camptothecin Derivatives.

M. Ciomei, W. Cabri, A. Bedeschi, 1996 .

Dioxin and Ecological Risk Assessment

D. Ballinari, E. Pesenti, G. Pezzoni, 1993, Environmental Health Perspectives.

Structure-activity relationship of novel tallimustine derivatives: synthesis and antitumor activity

G. Spalluto, B. Cacciari, P. Baraldi, 1996 .

Cytotoxic halogenoacrylic derivatives of distamycin A.

P. Cozzi, C. Geroni, M. Caldarelli, 2000, Bioorganic & medicinal chemistry letters.

Sequence-specific DNA alkylation of novel tallimustine derivatives.

M. Broggini, M. D’Incalci, S. Marchini, 1998, Anti-cancer drug design.

Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activity.

D. Ballinari, M. Ripamonti, L. Capolongo, 1994, Acta oncologica.

Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity.

G. Cristalli, E. Pesenti, S. Vittori, 1991, Journal of medicinal chemistry.